OncBioMune Pharmaceuticals Inc


By |


OncBioMune Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is engaged in the development of novel cancer immunotherapy products, with a proprietary vaccine technology that is designed to stimulate the immune system to attack its own cancer while not hurting the patient. The company also developing and commercializing specialty drugs in Mexico and other Latin American countries. The lead product candidate for the company is ProscaVax, which is a prostate cancer vaccine. In addition, the company has developed a mouse model to test a whole cell mouse mammary cancer vaccine.

Contact Information

Website: www.oncbiomune.com
Email: info@striker-energy.com
Main Phone: +1 225 227-2384
Address: 11441 Industriplex Boulevard
Address 2: Suite 190
State: LA
City / Town: Baton Rouge
Country: USA
Postal Code: 70809

Issuer Information

Exchange: OTO
Employees: 3
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.0111 $ -0.0009 (-7.50%)
Last Price 0.0111 Change $ -0.0009 Change % -7.50 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.01105 High 0.0138 Low 0.011 Prev Close 0.012
Last Trade Volume 948,013 52 Wk Hi 0.05 52 Wk Low 0.01
Market Cap 2.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 263,657,001.00 EPS (TTM) -0.09 PE Ratio N/A Exchange OTCPK